Health In Tech Launches HitRix Platform, Updates 2026 Revenue Guidance
HIT is trading near its 52-week low of $0.775 (4.7% above the low).
Summary
Health In Tech launched HitRix, a platform targeting the nearly $1 trillion U.S. self-funded health insurance market, and updated its 2026 full-year revenue guidance to approximately $33 million, roughly in line with 2025 revenue. The update follows a Q2 net loss of $2.5 million and a 14% revenue decline. The launch represents a new product initiative aimed at a large addressable market, while the guidance update signals management's revised outlook. Investors should watch for any details on HitRix's early traction.
Updated with an SEC 8-K filing · What changed
Updates
· SEC 8-K — Health In Tech expects FY2026 revenue of approximately $33 million, roughly in line with 2025 revenue.
At the time of this announcement, HIT was trading at $0.81 on NASDAQ in the Technology sector, with a market capitalization of approximately $53.1M. The 52-week trading range was $0.77 to $4.02. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: PR Newswire.